Comparison of results of excimer laser correction of all degrees of myopia at 12 months postoperatively. The Melbourne Excimer Laser Group

American Journal of Ophthalmology
C A McCartyH R Taylor

Abstract

To examine prospectively the efficacy and safety of photorefractive keratectomy and photoastigmatic refractive keratectomy. We treated 645 eyes (440 patients) with a VisX Twenty/Twenty excimer laser and followed them up for 12 months. The percentage of eyes with myopia between -5.01 and -10.00 diopters spherical equivalent within 1 and 2 diopters of emmetropia at 12 months was 65% (123 of 189) and 90% (170 of 189), respectively, whereas the corresponding percentages for eyes with myopia greater than -10.00 diopters spherical equivalent were 39% (16 of 41) and 56% (23 of 41), and for eyes with myopia of -5.00 diopters spherical equivalent or less, 87% (238 of 273) and 99% (270 of 273), respectively. Uncorrected visual acuity of 20/20 and 20/40 or better at 12 months was attained in 47% (129 of 273) and 87% (237 of 273) of the eyes with myopia -5.00 diopters spherical equivalent or less, respectively. At 12 months, 48 (25%) of the 189 eyes with myopia between -5.01 and -10.00 diopters spherical equivalent had uncorrected visual acuity of 6/6 or better and 135 (71%), 6/12. At 12 months, one eye (2%) with myopia greater than -10.00 diopters spherical equivalent had uncorrected visual acuity of 6/6 and 11 (27%) of 41 eyes, 6/12. Ten...Continue Reading

References

Sep 1, 1992·Archives of Ophthalmology·T SeilerT Pham
Jul 1, 1992·Archives of Ophthalmology·N A SherW B Telfair
Jan 1, 1995·Journal of Cataract and Refractive Surgery·S LevinH R Taylor
Jan 1, 1994·Transactions of the American Ophthalmological Society·H R Taylor, C A Carson
Mar 1, 1994·Journal of Cataract and Refractive Surgery·K DitzenE Schröder
May 1, 1994·Journal of Cataract and Refractive Surgery·W A Lyle, G J Jin
Sep 1, 1994·Ophthalmology·N A SherJ M Frantz
Apr 15, 1994·American Journal of Ophthalmology·D EpsteinH Hamberg-Nyström
Dec 1, 1993·Archives of Ophthalmology·J HeitzmannL T Nordan

❮ Previous
Next ❯

Citations

Mar 14, 2000·Journal of Cataract and Refractive Surgery·P Fagerholm
Apr 30, 2002·Journal of Cataract and Refractive Surgery·Ian F ComaishGerard L Sutton
Dec 25, 2002·Journal of Cataract and Refractive Surgery·Francesco CaronesLetizia Vacchini
May 30, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Noel A Brennan
Jan 26, 1999·Ophthalmology·R D StultingJ G Walker
Oct 13, 1998·Journal of Cataract and Refractive Surgery·A OzdamarR Aktunç
Nov 14, 1997·Journal of Cataract and Refractive Surgery·D K Williams
Jul 31, 2001·American Journal of Ophthalmology·J L AlióJ M Ruiz-Moreno
Apr 28, 2009·Journal of Cataract and Refractive Surgery·Eng K AngPaul N Baird
Dec 22, 2006·Expert Opinion on Drug Safety·Ali A Mearza, Ioannis M Aslanides
May 20, 1999·Journal of Cataract and Refractive Surgery·C P LohmannJ Marshall
Oct 18, 2000·Journal of Cataract and Refractive Surgery·H K Keskinbora
Jul 29, 2008·Journal of Cataract and Refractive Surgery·Bahri AydinHikmet Hasiripi
May 1, 1997·Journal of Cataract and Refractive Surgery·W B JacksonE J Casson
Mar 20, 2003·Journal of the American Podiatric Medical Association·Craig PayneKathryn Miller
Apr 24, 2003·Acta Ophthalmologica Scandinavica. Supplement·Torben Møller-Pedersen
Sep 29, 2000·Cornea·R D StultingJ D Carr
Sep 24, 1999·Postgraduate Medicine·I M ChaudhryR F Steinert
Sep 25, 2008·Journal of Refractive Surgery·Vinícius Coral GhanemSamuel Angelo Coral

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.